{
  "company": "Revvity",
  "ticker": "RVTY",
  "period": {
    "from": "2026-02-26",
    "to": "2026-03-28",
    "days": 30
  },
  "sentiment_breakdown": {
    "positive": 8,
    "negative": 2,
    "neutral": 18
  },
  "synthesis": {
    "executive_summary": "**Executive Summary: Revvity (RVTY) Sentiment Analysis**\n\nSentiment analysis for Revvity (RVTY) from February 26 to March 28, 2026, indicates a predominantly neutral market perception, with 18 out of 28 tracked items (64.3%) falling into this category. Among the remaining items, positive sentiment significantly outweighs negative, with 8 positive instances (28.6%) compared to just 2 negative (7.1%). Key drivers of positive sentiment include advancements in medical diagnostics, particularly research on placental growth factor-based testing for pre-eclampsia and the application of rapid molecular diagnostic tests in intensive care. However, it's important to note that some positive signals were derived from generic market trend indicators or unrelated content, which may not directly reflect company-specific sentiment.\n\nThe most significant positive developments include a cost comparison study supporting repeat placental growth factor-based testing, a core area for Revvity's diagnostics segment, and research exploring clinicians' perceptions of rapid molecular diagnostic tests. Conversely, negative sentiment was observed in medical research discussing \"Inhalable Ultrasound Contrast Agent with Induced Microbubble Destruction\" and \"Angiogenic Biomarkers and Neonatal Outcomes in Suspected Preeclampsia.\" While these studies carry negative sentiment within their specific research contexts, their direct impact on Revvity's operational performance or product portfolio is not explicitly detailed in the provided data. Overall, the sentiment suggests a stable, albeit largely neutral, outlook with specific positive indicators in diagnostic research.",
    "key_findings": [
      "✓ Send a Free Postcard at PAX East 💌 Pelican Post (Booth #20084)",
      "✓ Cost Comparison of Repeat Placental Growth Factor-Based Testing in Women with Suspected Preterm Pre-eclampsia, Compared to Usual Care: The PARROT-2 Trial.",
      "✓ Machine says go, doctor says no: an ecological momentary assessment analysis examining clinicians' perceptions of, and their antibiotic prescribing behaviour when using rapid molecular diagnostic tests in intensive care.",
      "✗ Inhalable Ultrasound Contrast Agent with Induced Microbubble Destruction and Associated Biological Effects on the Respiratory Epithelium, In Vitro.",
      "✗ Angiogenic Biomarkers and Neonatal Outcomes in Suspected Preeclampsia: Retrospective Cohort Study."
    ],
    "overall_sentiment": "positive"
  },
  "top_positive": [
    {
      "title": "Send a Free Postcard at PAX East 💌 Pelican Post (Booth #20084)",
      "date": "2026-03-25",
      "source": "reddit",
      "score": 0.818
    },
    {
      "title": "Cost Comparison of Repeat Placental Growth Factor-Based Testing in Women with Suspected Preterm Pre-eclampsia, Compared to Usual Care: The PARROT-2 Trial.",
      "date": "2026-03-28",
      "source": "pubmed",
      "score": 0.599
    },
    {
      "title": "Machine says go, doctor says no: an ecological momentary assessment analysis examining clinicians' perceptions of, and their antibiotic prescribing behaviour when using rapid molecular diagnostic tests in intensive care.",
      "date": "2026 Mar 2",
      "source": "pubmed",
      "score": 0.494
    },
    {
      "title": "EverHint – EMA10 × EMA30 Crossover – Top 10 Buy and Top 10 Sell Signals for Mar 25, 2026",
      "date": "2026-03-26",
      "source": "reddit",
      "score": 0.382
    },
    {
      "title": "EverHint – SMA20 × SMA50 Crossover – Top 10 Buy and Top 10 Sell Signals for Feb 25, 2026",
      "date": "2026-02-26",
      "source": "reddit",
      "score": 0.382
    },
    {
      "title": "EverHint Lens - Hims & Hers Health, Inc. (HIMS) - Yahoo Top Gainer (+40%) Stock Analysis - March 09, 2026",
      "date": "2026-03-09",
      "source": "reddit",
      "score": 0.202
    },
    {
      "title": "EverHint – EMA10 × Price × MACD – Top 10 Buy Signals for Mar 04, 2026",
      "date": "2026-03-05",
      "source": "reddit",
      "score": 0.202
    },
    {
      "title": "EverHint – EMA10 × Price × MACD – Top 10 Buy Signals for Mar 24, 2026",
      "date": "2026-03-25",
      "source": "reddit",
      "score": 0.202
    }
  ],
  "top_negative": [
    {
      "title": "Inhalable Ultrasound Contrast Agent with Induced Microbubble Destruction and Associated Biological Effects on the Respiratory Epithelium, In Vitro.",
      "date": "2026 Mar 9",
      "source": "pubmed",
      "score": -0.572
    },
    {
      "title": "Angiogenic Biomarkers and Neonatal Outcomes in Suspected Preeclampsia: Retrospective Cohort Study.",
      "date": "2026-03-28",
      "source": "pubmed",
      "score": -0.226
    }
  ],
  "raw_data": {
    "total_items": 28,
    "items": [
      {
        "source": "pubmed",
        "pmid": "41877199",
        "title": "Machine says go, doctor says no: an ecological momentary assessment analysis examining clinicians' perceptions of, and their antibiotic prescribing behaviour when using rapid molecular diagnostic tests in intensive care.",
        "authors": "Stewart SF et al.",
        "journal": "Antimicrobial resistance and infection control",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41877199/",
        "sentiment": {
          "label": "positive",
          "score": 0.494,
          "confidence": 0.49
        }
      },
      {
        "source": "pubmed",
        "pmid": "41858248",
        "title": "Prevalence and Predictors of Tuberculosis in Adults and Adolescents With Sputum Trace Ultra Results in 2 High-Burden Clinical Settings.",
        "authors": "Visek C et al.",
        "journal": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
        "date": "2026 Mar 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41858248/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41831164",
        "title": "PDXK Mutation Causes a Late-Onset Pyridoxal 5'-Phosphate-Responsive Peripheral Neuropathy Preceded by Neonatal Seizures: Authors' Reply.",
        "authors": "Arora A et al.",
        "journal": "Indian journal of pediatrics",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41831164/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41807232",
        "title": "Inhalable Ultrasound Contrast Agent with Induced Microbubble Destruction and Associated Biological Effects on the Respiratory Epithelium, In Vitro.",
        "authors": "Weitz AS et al.",
        "journal": "Ultrasound in medicine & biology",
        "date": "2026 Mar 9",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41807232/",
        "sentiment": {
          "label": "negative",
          "score": -0.572,
          "confidence": 0.57
        }
      },
      {
        "source": "pubmed",
        "pmid": "41774927",
        "title": "Measuring the Degree of Labeling of Antibody-Dye Conjugates with a Single-Molecule-Sensitive Digital Flow Cytometer.",
        "authors": "Cheng Y et al.",
        "journal": "Analytical chemistry",
        "date": "2026 Mar 1",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41774927/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41760611",
        "title": "Allosteric activation of the glutamate receptor mGlu2 by the serotonin receptor 5-HT(2A).",
        "authors": "Gai S et al.",
        "journal": "Nature communications",
        "date": "2026 Feb 2",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41760611/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41739160",
        "title": "[On the urgency of treating ophthalmic emergencies].",
        "authors": "Seitz IP et al.",
        "journal": "Die Ophthalmologie",
        "date": "2026-03-28",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41739160/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41493740",
        "title": "Cost Comparison of Repeat Placental Growth Factor-Based Testing in Women with Suspected Preterm Pre-eclampsia, Compared to Usual Care: The PARROT-2 Trial.",
        "authors": "Hurrell A et al.",
        "journal": "PharmacoEconomics - open",
        "date": "2026-03-28",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41493740/",
        "sentiment": {
          "label": "positive",
          "score": 0.599,
          "confidence": 0.6
        }
      },
      {
        "source": "pubmed",
        "pmid": "41468708",
        "title": "D-threo-chloramphenicol: tritium labelling at high specific activity.",
        "authors": "Carr S et al.",
        "journal": "Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine",
        "date": "2026-03-28",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41468708/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "pubmed",
        "pmid": "41355705",
        "title": "Angiogenic Biomarkers and Neonatal Outcomes in Suspected Preeclampsia: Retrospective Cohort Study.",
        "authors": "Fung GPG et al.",
        "journal": "BJOG : an international journal of obstetrics and gynaecology",
        "date": "2026-03-28",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41355705/",
        "sentiment": {
          "label": "negative",
          "score": -0.226,
          "confidence": 0.23
        }
      },
      {
        "source": "pubmed",
        "pmid": "41175037",
        "title": "In Vivo Performance of Airway and Lung Ultrasound Enhanced via Inhalable Contrast Agents.",
        "authors": "Weitz AS et al.",
        "journal": "Ultrasonic imaging",
        "date": "2026-03-28",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41175037/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "OGM_BionanoGenomics",
        "title": "The Power of Three“Revvity",
        "text": "**“Revvity is proud to integrate and market Bionano’s VIA™ software within our newborn sequencing research workflow.** This collaboration is intended to enhance CNV detection and interpretation alongside NGS, giving clinical and research laboratories a streamlined, turnkey option that lowers commercial friction for adopting complementary OGM capabilities.”\n\n**“NVIDIA is collaborating with Bionano to deliver GPU‑accelerated solutions for OGM secondary analysis that materially reduce processing ti",
        "author": "Incognew01",
        "score": 2,
        "num_comments": 0,
        "date": "2026-03-21",
        "url": "https://reddit.com/r/OGM_BionanoGenomics/comments/1rzpqn2/the_power_of_threerevvity/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "EverHint",
        "title": "EverHint Lens - Hims & Hers Health, Inc. (HIMS) - Yahoo Top Gainer (+40%) Stock Analysis - March 09, 2026",
        "text": "**Analysis Date** : 2026-03-09  \n**Sector** : Healthcare  \n**Industry** : Medical - Equipment & Services  \n**Exchange** : NYSE\n\n## Executive Summary\n\nHims & Hers Health, Inc. is currently trading at **$22.12** (🟢 +40.52% today) with a market capitalization of **$4.86B**.\n\nHims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase",
        "author": "Mamuthone125",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-09",
        "url": "https://reddit.com/r/EverHint/comments/1rp5lp9/everhint_lens_hims_hers_health_inc_hims_yahoo_top/",
        "sentiment": {
          "label": "positive",
          "score": 0.202,
          "confidence": 0.2
        }
      },
      {
        "source": "reddit",
        "subreddit": "EverHint",
        "title": "EverHint – EMA10 × Price × MACD – Top 10 Buy Signals for Mar 04, 2026",
        "text": "## What This Signal Is (Quick)\n\nThis is an **experimental strategy** that combines two bullish signals occurring on the **same day** :\n\n  1. **Price crosses above EMA10 from below**\n\n     * Yesterday: `price_prev <= ema10_prev`\n     * Today: `price > ema10`\n     * Indicates price breaking above short-term trend\n  2. **MACD Line crosses above Signal Line from below**\n\n     * Yesterday: `macd_line_prev <= macd_signal_prev`\n     * Today: `macd_line > macd_signal`\n     * Confirms bullish momentum sh",
        "author": "Mamuthone125",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-05",
        "url": "https://reddit.com/r/EverHint/comments/1rl709d/everhint_ema10_price_macd_top_10_buy_signals_for/",
        "sentiment": {
          "label": "positive",
          "score": 0.202,
          "confidence": 0.2
        }
      },
      {
        "source": "reddit",
        "subreddit": "OGM_BionanoGenomics",
        "title": "Revvity Acquires ACD/Labs",
        "text": "ACD/Labs is a Toronto software company that makes analytical‑chemistry tools (like Spectrus and Percepta) used by pharma, chemical, and materials researchers worldwide; it has a global customer base and a few hundred employees.\n\nRevvity already has a **software marketing agreement** to market Bionano’s **VIA** to Revvity’s NGS customers, specifically to add **Copy Number Variant assessment** into newborn sequencing workflows.\n\nRevvity’s purchase of ACD/Labs should **help, not hurt**, Revvity’s e",
        "author": "Incognew01",
        "score": 1,
        "num_comments": 1,
        "date": "2026-03-15",
        "url": "https://reddit.com/r/OGM_BionanoGenomics/comments/1rubehz/revvity_acquires_acdlabs/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "CrownElectrokinetics",
        "title": "The Power of Three“Revvity",
        "text": "",
        "author": "Incognew01",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-21",
        "url": "https://reddit.com/r/CrownElectrokinetics/comments/1rzpqtk/the_power_of_threerevvity/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "CrownElectrokinetics",
        "title": "Revvity Acquires ACD/Labs",
        "text": "",
        "author": "Incognew01",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-15",
        "url": "https://reddit.com/r/CrownElectrokinetics/comments/1rubeno/revvity_acquires_acdlabs/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "TMKOC",
        "title": "25,000rs envelope arc",
        "text": "I don't think jetha should've given money to that guy for beshisht mhataras mistake \n\nBhidu, popu and champhuck couldn't even wait for a day and jetha had to pay for it ",
        "author": "Shiroyasha_a",
        "score": 170,
        "num_comments": 15,
        "date": "2026-03-07",
        "url": "https://reddit.com/r/TMKOC/comments/1rneqke/25000rs_envelope_arc/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "AdoptMeTrading",
        "title": "Trading!",
        "text": "Favorite = Fully Grown!\n+ Mega Walrus!\nLocked = NFT",
        "author": "Design_Major5744",
        "score": 16,
        "num_comments": 36,
        "date": "2026-02-27",
        "url": "https://reddit.com/r/AdoptMeTrading/comments/1rfskfk/trading/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "stockstobuytoday",
        "title": "What are you guys looking at today?",
        "text": "I'm still holding ANNA, but what else are you guys looking at?",
        "author": "cabinontheland",
        "score": 13,
        "num_comments": 25,
        "date": "2026-03-06",
        "url": "https://reddit.com/r/stockstobuytoday/comments/1rmd1fc/what_are_you_guys_looking_at_today/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "PAX",
        "title": "Send a Free Postcard at PAX East 💌 Pelican Post (Booth #20084)",
        "text": "Send a free postcard from Port Pleasant 💌\n\nWe’re at Booth #20084 with MAGIC Spell Studios, where you can write and send a real postcard (we’ll cover postage!) straight from the world of Pelican Post.\n\nWe wanted to bring the world of Pelican Post to life at PAX, creating a space centered around community and connection.\n\nWe also have a live demo running all weekend, so you can experience our cozy, narrative-driven mail delivery game firsthand.\n\nCome stop by, play, and experience a piece of Port P",
        "author": "PelicanPost",
        "score": 76,
        "num_comments": 8,
        "date": "2026-03-25",
        "url": "https://reddit.com/r/PAX/comments/1s3r5az/send_a_free_postcard_at_pax_east_pelican_post/",
        "sentiment": {
          "label": "positive",
          "score": 0.818,
          "confidence": 0.82
        }
      },
      {
        "source": "reddit",
        "subreddit": "NIPT",
        "title": "Any experts on Z-scores?",
        "text": "My NIPT results is positive for trisomy 21. I know that only an amnio provides certainty. But after three miscarriages, I don’t want to take the risk. I’ve done some research on Z-scores. The manufacturer Vanadis/Revvity provides a table for the positive predictive value (PPV). According to this, the PPV is 50% for a Z-score <5. The lab and my doctor aren’t aware of this and say a positive result is 99% accurate. Also, there’s no fetal fraction listed. Could the Z-score be low because there’s on",
        "author": "Thin_Palpitation8768",
        "score": 1,
        "num_comments": 17,
        "date": "2026-03-20",
        "url": "https://reddit.com/r/NIPT/comments/1ryrdnl/any_experts_on_zscores/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "OGM_BionanoGenomics",
        "title": "Reasons Behind the Uptick",
        "text": "While there’s no single flashy headline driving it, the underlying reasons seem pretty clear. Hospitals and research centers tend to move quietly at first, but the combination of the new CPT codes, growing validation data, and partnerships with companies like Revvity, NVIDIA, and Hangzhou Diagens suggests that more institutions are finally taking OGM seriously. These aren’t casual collaborations…they signal that the technology is scalable, clinically relevant, and increasingly aligned with where",
        "author": "Incognew01",
        "score": 1,
        "num_comments": 1,
        "date": "2026-03-23",
        "url": "https://reddit.com/r/OGM_BionanoGenomics/comments/1s1qqp2/reasons_behind_the_uptick/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "EverHint",
        "title": "EverHint – EMA10 × EMA30 Crossover – Top 10 Buy and Top 10 Sell Signals for Mar 25, 2026",
        "text": "## What This Signal Is (Quick)\n\nThis strategy detects **fresh crossovers** between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30):\n\n  * **Buy Signal (EMA10_x_EMA30_Buy)** : EMA(10) crosses **above** EMA(30) on today's close\n\n    * Short-term momentum overtakes medium-term trend\n    * Suggests acceleration in upward price movement\n    * Ideal for swing trading (1-4 week holding periods)\n  * **Sell Signal (EMA10_x_EMA30_Sell)** : EMA(10) crosses **b",
        "author": "Mamuthone125",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-26",
        "url": "https://reddit.com/r/EverHint/comments/1s3xb55/everhint_ema10_ema30_crossover_top_10_buy_and_top/",
        "sentiment": {
          "label": "positive",
          "score": 0.382,
          "confidence": 0.38
        }
      },
      {
        "source": "reddit",
        "subreddit": "EverHint",
        "title": "EverHint – EMA10 × Price × MACD – Top 10 Buy Signals for Mar 24, 2026",
        "text": "## What This Signal Is (Quick)\n\nThis is an **experimental strategy** that combines two bullish signals occurring on the **same day** :\n\n  1. **Price crosses above EMA10 from below**\n\n     * Yesterday: `price_prev <= ema10_prev`\n     * Today: `price > ema10`\n     * Indicates price breaking above short-term trend\n  2. **MACD Line crosses above Signal Line from below**\n\n     * Yesterday: `macd_line_prev <= macd_signal_prev`\n     * Today: `macd_line > macd_signal`\n     * Confirms bullish momentum sh",
        "author": "Mamuthone125",
        "score": 2,
        "num_comments": 0,
        "date": "2026-03-25",
        "url": "https://reddit.com/r/EverHint/comments/1s32a08/everhint_ema10_price_macd_top_10_buy_signals_for/",
        "sentiment": {
          "label": "positive",
          "score": 0.202,
          "confidence": 0.2
        }
      },
      {
        "source": "reddit",
        "subreddit": "InternshipDrops",
        "title": "Today’s tech internships: software, data, and ML roles",
        "text": "See more on \\[internshipdaily.com/internships?category=software\\_engineering\\](https://internshipdaily.com/internships?category=software\\_engineering)\n\nHey everyone, some solid tech internships posted today. No Google/Meta this time, but plenty of hands-on gigs in software, data, and ML.\n\n\\*\\*tateandlyle - Master Data Trainee\\*\\*\nLodz, poland\nhttps://tateandlyle.wd3.myworkdayjobs.com/en-US/tlcareers/job/Lodz/Master-Data-Trainee\\_JREQ10134\n\n\\*\\*vanderlande - Internship: AI Workbench Development &",
        "author": "Altruistic_Hunt_4369",
        "score": 4,
        "num_comments": 0,
        "date": "2026-03-20",
        "url": "https://reddit.com/r/InternshipDrops/comments/1rz9u31/todays_tech_internships_software_data_and_ml_roles/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "OGM_BionanoGenomics",
        "title": "Bionano: Stuctural Variant Diva",
        "text": "**Bionano Genomics** looks well positioned to lead in **structural variant** detection by combining its optical mapping platform with two powerful partners: **NVIDIA** and **Revvity**. NVIDIA’s GPUs and genomics software can speed up the heavy data analysis needed to find large DNA changes, turning days of computation into hours and making results more consistent and scalable for labs. Revvity brings lab workflows, distribution, and credibility that can help embed Bionano’s VIA software into rou",
        "author": "Incognew01",
        "score": 1,
        "num_comments": 0,
        "date": "2026-03-02",
        "url": "https://reddit.com/r/OGM_BionanoGenomics/comments/1rirykd/bionano_stuctural_variant_diva/",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "reddit",
        "subreddit": "EverHint",
        "title": "EverHint – SMA20 × SMA50 Crossover – Top 10 Buy and Top 10 Sell Signals for Feb 25, 2026",
        "text": "## What This Signal Is (Quick)\n\nThis strategy detects **fresh crossovers** between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50):\n\n  * **Buy Signal (SMA20_x_SMA50_Buy) - \"Golden Cross\"** : SMA(20) crosses **above** SMA(50) on today's close\n\n    * Short-term momentum (20 days) exceeds medium-term trend (50 days)\n    * Bullish trend confirmation with high reliability\n    * Ideal for medium-term trend following (4-12 week holding periods)\n  * **Sell Signal (S",
        "author": "Mamuthone125",
        "score": 1,
        "num_comments": 0,
        "date": "2026-02-26",
        "url": "https://reddit.com/r/EverHint/comments/1rf31xr/everhint_sma20_sma50_crossover_top_10_buy_and_top/",
        "sentiment": {
          "label": "positive",
          "score": 0.382,
          "confidence": 0.38
        }
      }
    ]
  }
}